Genetic variations in the PI3K/PTEN/AKT/mTOR pathway predict tumor response and disease-free survival in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy and radical surgery.
PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy.
Lung Cancer (Amsterdam, Netherlands)
Pu, Xia X; Hildebrandt, Michelle A T MA; Lu, Charles C; Lin, Jie J; Stewart, David J DJ; Ye, Yuanqing Y; Gu, Jian J; Spitz, Margaret R MR; Wu, Xifeng X
Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer.
British Journal Of Cancer
Quaye, L L; Song, H H; Ramus, S J SJ; Gentry-Maharaj, A A; Høgdall, E E; DiCioccio, R A RA; McGuire, V V; Wu, A H AH; Van Den Berg, D J DJ; Pike, M C MC; Wozniak, E E; Doherty, J A JA; Rossing, M A MA; Ness, R B RB; Moysich, K B KB; Høgdall, C C; Blaakaer, J J; , ; Easton, D F DF; Ponder, B A J BA; Jacobs, I J IJ; Menon, U U; Whittemore, A S AS; Krüger-Kjaer, S S; Pearce, C L CL; Pharoah, P D P PD; Gayther, S A SA
Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.
Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology
Hildebrandt, Michelle A T MA; Yang, Hushan H; Hung, Mien-Chie MC; Izzo, Julie G JG; Huang, Maosheng M; Lin, Jie J; Ajani, Jaffer A JA; Wu, Xifeng X